PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-07

Date Title Company
07-Oct-2025 Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology Businesswire
07-Oct-2025 EU and US Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Market Authorisation Training Course (Nov 10th - Nov 11th, 2025) - ResearchAndMarkets.com Businesswire
07-Oct-2025 Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA Hikma
07-Oct-2025 Resmed Launches AirTouch N30i in the UK Resmed
07-Oct-2025 Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View ACCESS Newswire
07-Oct-2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Onco3R Therapeutics
07-Oct-2025 RETRANSMISSION UniDoc Announces LIFE Offering ACCESS Newswire
07-Oct-2025 Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer Theolytics
07-Oct-2025 Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025 Resolution Therapeutics
07-Oct-2025 appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate Bioxodes
07-Oct-2025 Clinical Trial Management System Market Key Players, Share and Forecast Outlook VMR
07-Oct-2025 Medical Care Technologies (OTC Pink:MDCE) Outlines Regulatory Roadmap: Dividing AI Health Platform Into Clinical and Consumer Divisions ACCESS Newswire
07-Oct-2025 RIBOMIC Announces Positive Phase 2 Cohort 2 Results for Umedaptanib Pegol in Achondroplasia, Demonstrating an Increase in the Annualized Growth Rate of up to +5.0 cm/year with Biweekly Administration in Children Aged 5 Years and Older Businesswire
07-Oct-2025 CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B CSL Behring
07-Oct-2025 2026 State of Release of Information Technology Report Reveals Market Consolidation, AI Integration, and Escalating Compliance Risks ACCESS Newswire
07-Oct-2025 IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease ACCESS Newswire
07-Oct-2025 Beyond the Cuts: How Rural Hospitals Are Finding Growth Through Strategic Partnerships ACCESS Newswire
07-Oct-2025 Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer Businesswire
07-Oct-2025 Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit ACCESS Newswire
07-Oct-2025 Momentum Consulting Collaborates With Robert Michel to Help Hospital Laboratories Build Local Services and Revenue ACCESS Newswire